LLY Competitors
Eli Lilly and Company
$1,208.74
+$42.23(+3.62%)
60
Overall
45
Value
66
Tech
71
Quality
Market Cap
$1.14T
Volume
3.15M
52W Range
$783.85 - $1,292.65
Target Price
$1,357.04
LLY competitors: BMY, MRK, JNJ, PFE, SNY. Eli Lilly and Company is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
LLY Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| BMY Bristol-Myers Squibb Company | $59.28 | $121.09B | $6.80 | 3.19% | 63 |
| MRK Merck & Co., Inc. | $147.37 | $350.29B | $2.66 | 2.31% | 67 |
| JNJ Johnson & Johnson | $253.91 | $599.12B | $11.09 | 2.08% | 56 |
| PFE Pfizer Inc. | $29.21 | $166.49B | $2.96 | 5.89% | 70 |
| SNY Sanofi | $39.77 | $95.41B | $5.00 | 6.08% | 60 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LLY | $1,208.74 | +3.6% | 3.15M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |